国立大学法人 浜松医科大学

教育

Education

研究業績

原著論文

2019

  • Higashida H, Munesue T, Kosaka H, Yamasue H, Yokoyama S, Kikuchi M. Social Interaction Improved by Oxytocin in the Subclass of Autism with Comorbid Intellectual Disabilities. Diseases. 2019 Feb 22;7(1).Benner S, Aoki Y, Watanabe T, Endo N, Abe O, Kuroda M, Kuwabara H, Kawakubo Y, Takao H, Kunimatsu A, Kasai K, Bito H, Kakeyama M, Yamasue H: Neurochemical evidence for differential effects of acute and repeated oxytocin administration, Mol Psychiatry, 2018. [Epub ahead of print]
  • Iwashiro N, Takano Y, Natsubori T, Aoki Y, Yahata N, Gonoi W, Kunimatsu A, Abe O, Kasai K, Yamasue H*. Aberrant attentive and inattentive brain activity to auditory negative words, and its relation to persecutory delusion in patients with schizophrenia. Neuropsychiatr Dis Treat. 2019 Feb 14;15:491-502.

2018*責任著者)

  • Yamasue H*, Okada T, Munesue T, Kuroda M, Fujioka T, Uno Y, Matsumoto K, Kuwabara H, Mori D, Okamoto Y, Yoshimura Y, Kawakubo Y, Arioka Y, Kojima M, Yuhi T, Owada K, Yassin W, Kushima I, Benner S, Ogawa N, Eriguchi Y, Kawano N, Uemura Y, Yamamoto M, Kano Y, Kasai K, Higashida H, Ozaki N, Kosaka H. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: A randomized clinical trial. Mol Psychiatry. 2018 Jun 29. doi: 10.1038/s41380-018-0097-2. [Epub ahead of print].
  • Benner S, Aoki Y, Watanabe T, Endo N, Abe O, Kuroda M, Kuwabara H, Kawakubo Y, Takao H, Kunimatsu A, Kasai K, Bito H, Kakeyama M, Yamasue H: Neurochemical evidence for differential effects of acute and repeated oxytocin administration, Mol Psychiatry, 2018. [Epub ahead of print]
  • Matsunaga M, Masuda T, Ishii K, Ohtsubo Y, Noguchi Y, Ochi M, Yamasue H. Culture and cannabinoid receptor gene polymorphism interact to influence the perception of happiness. PLoS One. 2018 Dec 21;13(12):e0209552. doi: 10.1371/journal.pone.0209552.
  • Kushima I, Aleksic B, Nakatochi M, Shimamura T, Okada T, Uno Y, Morikawa M, Ishizuka K, Shiino T, Kimura H, Arioka Y, Yoshimi A, Takasaki Y, Yu Y, Nakamura Y, Yamamoto M, Iidaka T, Iritani Shuji, Inada T, Ogawa N, Shishido E, Torii Youta, Kawano N, Omura Y, Yoshikawa T, Uchiyama T, Yamamoto T, Ikeda M, Hashimoto R, Yamamori H, Yasuda Y, Someya T, Watanabe Y, Egawa J, Nunokawa A, Itokawa M, Arai M, Miyashita M, Kobori A, Suzuki M, Takahashi T, Usami M, Kodaira M, Watanabe K, Sasaki T, Kuwabara H, Tochigi M, Nishimura F, Yamasue H, Eriguchi Y, Benner S, Kojima M, Yassin W, Munesue T, Yokoyama S, Kimura R, Funabiki Y, Kosaka H, Ishitobi M, Ohmori T, Numata S, Yoshikawa T, Toyota T, Yamakawa K, Suzuki T, Inoue Y, Nakaoka K, Goto Y, Inagaki M, Hashimoto N, Kusumi I, Son S, Murai T, Ikegame T, Okada N, Kasai K, Kunimoto S, Mori D, Iwata N, Ozaki N. Comparative analyses of copy number variation in autism spectrum disorder and schizophrenia reveal etiological overlap and biological insights. Cell Reports. 9th Aug 2018 accepted
  • Ikeda M, Takahashi A, Kamatani Y, Momozawa Y, Saito T, Kondo K, Shimasaki A, Kawase K, Sakusabe T, Iwayama Y, Toyota T, Wakuda T, Kikuchi M, Kanahara N, Yamamori H, Yasuda Y, Watanabe Y, Hoya S, Aleksic B, Kushima I, Arai H, Takaki M, Hattori K, Kunugi H, Okahisa Y, Ohnuma T, Ozaki N, Someya T, Hashimoto R, Yoshikawa T, Kubo M, Iwata N. Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect. Schizophr Bull. Oct 3. doi: 10.1093/schbul/sby140. 2018.
  • Kojima M, Yassin W, Owada K, Aoki Y, Kuwabara H, Natsubori T, Iwashiro N, Gonoi W, Takao H, Kasai K, Abe O, Kano Y, Yamasue H*. Neuroanatomical Correlates of Advanced Paternal and Maternal Age at Birth in Autism Spectrum Disorder. Cereb Cortex. 2018 May 25. doi: 10.1093/cercor/bhy122. [Epub ahead of print]
  • Benner S, Yamasue H*. Clinical potential of oxytocin in autism spectrum disorder: current issues and future perspectives. Behav Pharmacol. 2018 Feb;29(1):1-12.
  • Yamasue H*, Domes G. Oxytocin and Autism Spectrum Disorders. Curr Top Behav Neurosci. 2017 Aug 2.
  • Nakaizumi K, Ouchi Y, Terada T, Yoshikawa E, Kakimoto A, Isobe T, Bunai T, Yokokura M, Suzuki K, Magata Y.: In vivo depiction of α7 nicotinic receptor loss for cognitive decline in Alzheimer's disease. J Alzheimers Dis. 61(4):1355-1365, 2018.
  • Bunai T, Terada T, Kono S, Yokokura M, Yoshikawa E, Futatsubashi M, Miyajima H, Ouchi Y.: Neuroinflammation following disease modifying therapy in multiple sclerosis: A pilot positron emission tomography study. J Neurol Sci. 15;385:30-33, 2018.
  • Owada K, Kojima M, Yassin W, Kuroda M, Kawakubo Y, Kuwabara H, Kano Y, Yamasue H*. Computer-analyzed facial expression as a surrogate marker for autism spectrum social core symptoms. PLoS One. 2018 Jan 2;13(1):e0190442.
  • Nakamura M, Takahashi T, Takayanagi Y, Sasabayashi D, Katagiri N, Sakuma A, Obara C, Koike S, Yamasue H, Furuichi A, Kido M, Nishikawa Y, Noguchi K, Matsumoto K, Mizuno M, Kasai K, Suzuki M.Surface morphology of the orbitofrontal cortex in individuals at risk of psychosis: a multicenter study. Eur Arch Psychiatry Clin Neurosci. 2018 Mar 23.

2017

  • Matsunaga M, Kawamichi H, Umemura T, Hori R, Shibata E, Kobayashi F, Suzuki K, Ishii K, Ohtsubo Y, Noguchi Y, Ochi M, Yamasue H, Ohira H. Neural and Genetic Correlates of the Social Sharing of Happiness. Front Neurosci. 2017;11:718.
  • Sasabayashi D, Takayanagi Y, Takahashi T, Koike S, Yamasue H, Katagiri N, Sakuma A, Obara C, Nakamura M, Furuichi A, Kido M, Nishikawa Y, Noguchi K, Matsumoto K, Mizuno M, Kasai K, Suzuki M. Increased occipital gyrification and development of psychotic disorders in individuals with an at-risk mental state: a multicenter study. Biological Psychiatry, 2017;82:737-745.
  • Matsunaga M, Ishii K, Ohtsubo Y, Noguchi Y, Ochi M, Yamasue H. Association between salivary serotonin and the social sharing of happiness. PLOS ONE, 2017;12(7):e0180391.
  • Hashimoto N, Ito YM, Okada N, Yamamori H, Yasuda Y, Fujimoto M, Kudo N, Takemura A, Son S, Narita H, Yamamoto M, Tha KK, Katsuki A, Ohi K, Yamashita F, Koike S, Takahashi T, Nemoto K, Fukunaga M, Onitsuka T, Watanabe Y, Yamasue H, Suzuki M, Kasai K, Kusumi I, Hashimoto R. The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjects. Neuroimage Clin. 2017;17:563-569.
  • Paparelli A, Iwata K, Wakuda T, Iyegbe C, Murray RM, Takei N. Perinatal Asphyxia in Rat Alters Expression of Novel Schizophrenia Risk Genes. Front Mol Neurosci. 10:341, 2017.
  • Fukai M, Hirosawa T, Kikuchi M, Ouchi Y, Takahashi T, Yoshimura Y, Miyagishi Y, Kosaka H, Yokokura M, Yoshikawa E, Bunai T, Minabe Y.: Oxytocin effects on emotional response to others' faces via serotonin system in autism: A pilot study. Psychiatry Res. Jun 28;267:45-50, 2017
  • Balan S, Kameno Y: Comprehensive association analysis of 27 genes from the GABAergic system in Japanese individuals affected with schizophrenia., Schizophr Res., 185, 33-40. 2017.
  • 望月洋介,奈良岡悠己,井上淳,高貝就,星野良一:追体験入院の適切な運用方法構築のための基礎的研究,メンタルヘルス岡本記念財団研究助成報告集28,137-141,2017.
  • Yokokura M, Terada T, Bunai T, Nakaizumi K, Takebayashi K, Iwata Y, Yoshikawa E, Futatsubashi M, Suzuki K, Mori N, Ouchi Y: Depiction of microglial activation in aging and dementia: Positron emission tomography with [11C]DPA713 versus [11C](R)PK11195. J Cereb Blood Flow Metab 37(3): 877-889, 2017.
  • Takano Y, Aoki Y, Yahata N, Kawakubo Y, Inoue H, Iwashiro N, Natsubori T, Koike S, Gonoi W, Sasaki H, Takao H, Kasai K, Yamasue H*. Neural basis for inferring false beliefs and social emotions in others among individuals with schizophrenia and those at ultra-high risk for psychosis. Psychiatry Research: Neuroimaging 2017; 259:34-41.
  • Watanabe T, Otowa T, Abe O, Kuwabara H, Aoki Y, Natsubori T, Takao H, Kakiuchi C, Kondo K, Ikeda M, Iwata N, Kasai K, Sasaki T, Yamasue H*. Oxytocin receptor gene variations predict neural and behavioral response to oxytocin in autism. Social Cognitive and Affective Neuroscience 2017;12(3):496-506.
  • Balan S, Yamada K, Iwayama Y, Hashimoto T, Toyota T, Shimamoto C, Maekawa M, Takagai S, Wakuda T, Kameno Y, Kurita D, Yamada K, Kikuchi M, Hashimoto T, Kanahara N, Yoshikawa T. Comprehensive association analysis of 27 genes from the GABAergic system in Japanese individuals affected with schizophrenia. Schizophr Res.pii: S0920-9964(17)30003-8. 2017.
  • Hirosawa T, Kikuchi M, Ouchi Y, Takahashi T, Yoshimura Y, Kosaka H, Furutani N, Hiraishi H, Fukai M, Yokokura M, Yoshikawa E, Bunai T, Minabe Y: A pilot study of serotonergic modulation after long-term administration of oxytocin in autism spectrum disorder. Autism Res. 2017 Mar 7 [Epub ahead of print]

2016

  • Kameno Y, Suzuki K, Takagai S, Iwata K, Matsuzaki H, Takahashi K, Wakuda T, Iwata Y, Magata Y, Mori N: Mismatch in cerebral blood flow and glucose metabolism after the forced swim stress in rats., Acta Neuropsychiatr, 28, 6, 352-356, 2016.
  • Terada T, Yokokura M, Yoshikawa E, Futatsubashi M, Kono S, Konishi T, Miyajima H, Hashizume T, Ouchi Y: Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study. Ann Nucl Med 30(8): 579-587, 2016
  • Kosaka H, Okamoto Y, Munesue T, Yamasue H, Inohara K, Fujioka T, Anme T, Orisaka M, Ishitobi M, Jung M, Fujisawa T, Tanaka S, Arai S, Asano M, Saito D, Sadato N, Tomoda A, Omori M, Sato M, Okazawa H, Higashida H, Wada Y. Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: A 24-week randomized clinical trial. Transl Psychiatry 2016;6(8):e872.
  • Okada N, Fukunaga M, Yamashita F, Koshiyama D, Yamamori H, Isobe M, Isomura S, Natsubori T, Narita H, Hashimono N, Miyata J, Koike S, Takahashie T, Yamasue H, Matsuo K, Onitsuka T, Iidaka T, Kawasaki Y, Yoshimura R, Watanabe Y, Suzuki M, Turner JA, Takeda M, Thompson PM, Osaki N, Kasai K, Hashimoto R. Abnomal asymmertries in subcorticl brain volume in schizophrenia. Mol Psychiatry. 2016;21(10):1460-6.
  • Fujioka T, Inohara K, Okamoto Y, Masuya Y, Ishitobi M, Saito DN, Jung M, Arai S, Matsumura Y, Fujisawa TX, Narita K, Suzuki K, Tsuchiya KJ, Mori N, Katayama T, Sato M, Munesue T, Okazawa H, Tomoda A, Wada Y, Kosaka H*: Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults, Mol Autism, 7:19, 2016.
  • Nishimura T, Takei N*, Tsuchiya KJ, Asano R, Mori N: Identification of neurodevelopmental trajectories in infancy and of risk factors affecting deviant development: a longitudinal birth cohort study, Int J Epidemiol, pii:dyv363, 2016.
  • Liu X, Shimada T, Otowa T, Wu YY, Kawamura Y, Tochigi M, Iwata Y, Umekage T, Toyota T, Maekawa M, Iwayama Y, Suzuki K, Kakiuchi C, Kuwabara H, Kano Y, Nishida H, Sugiyama T, Kato N, Chen CH, Mori N, Yamada K, Yoshikawa T, Kasai K, Tokunaga K, Sasaki T*, Gau SS*: Genome-wide association study of autism spectrum disorder in the east asian populations, Autism Res, 9:340-349, 2016.
  • Tang Y, Han S, Asakawa T, Luo Y, Han X, Xiao B, Dong Q, Lu C, Wang L*: Effects of intracerebral hemorrhage on 5-hydroxymethylcytosine modification in mouse brain, Neuropsychiatr Dis Treat, 12:617-624, 2016.

2015

  • Inoue J, Hoshino R, Nojima H, Ishida W and Okamoto N: Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression, Psychogeriatrics, 16: 54-61, 2015.
  • Takagai S, Tsuchiya KJ*, Itoh H, Kanayama N, Mori N, Takei N: Cohort profile: Hamamatsu Birth Cohort for Mothers and Children (HBC Study), Int J Epidemiol, 5(2):333-42., 2015.
  • Maekawa M, Iwayama Y, Ohnishi T, Toyoshima M, Shimamoto C, Hisano Y, Toyota T, Balan S, Matsuzaki H, Iwata Y, Takagai S, Yamada K, Ota M, Fukuchi S, Okada Y, Akamatsu W, Tsujii M, Kojima N, Owada Y, Okano H, Mori N, Yoshikawa T*: Investigation of the fatty acid transporter-encoding genes SLC27A3 and SLC27A4 in autism, Sci Rep, 5:16239, 2015.
  • Yamada K, Hattori E, Iwayama Y, Toyota T, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Mori N, Yoshikawa T*: Population-dependent contribution of the major histocompatibility complex region to schizophrenia susceptibility. Schizophr Res, 168:444-449, 2015.
  • Miyaoka T*, Furuya M, Horiguchi J, Wake R, Hashioka S, Thoyama M, Murotani K, Mori N, Minabe Y, Iyo M, Ueno S, Ezoe S, Hoshino S, Seno H: Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, multicenter, double-blind, placebo-controlled trial, Evid Based Complement Alternat Med, 2015:201592, 2015.
  • Yamagishi S*, Yamada K, Sawada M, Nakano S, Mori N, Sawamoto K, Sato K: Netrin-5 is highly expressed in neurogenic regions of the adult brain, Front Cell Neurosci, 9:146, 2015.
  • Shimamoto C, Ohnishi T, Maekawa M, Watanabe A, Ohba H, Arai R, Iwayama Y, Hisano Y, Toyota T, Toyoshima M, Suzuki K, Shirayama Y, Nakamura K, Mori N, Owada Y, Kobayashi T, Yoshikawa T*: Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies, Hum Mol Genet, 24:2409, 2015.
  • Bangel FN, Yamada K, Arai M, Iwayama Y, Balan S, Toyota T, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Mori N, Itokawa M, Stork O, Yoshikawa T*: Genetic analysis of the glyoxalase system in schizophrenia, Prog Neuropsychopharmacol Biol Psychiatry, 59:105-110, 2015.
  • Maekawa M, Yamada K, Toyoshima M, Ohnishi T, Iwayama Y, Shimamoto C, Toyota T, Nozaki Y, Balan S, Matsuzaki H, Iwata Y, Suzuki K, Miyashita M, Kikuchi M, Kato M, Okada Y, Akamatsu W, Mori N, Owada Y, Itokawa M, Okano H, Yoshikawa T*: Utility of scalp hair follicles as a novel source of biomarker genes for psychiatric illnesses, Biol Psychiatry, 78:116-125, 2015.
  • Jitoku D, Yamamoto N, Iwayama Y, Toyota T, Miyagi M, Enokida T, Tasaka Y, Umino M, Umino A, Uezato A, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Kurumaji A, Yoshikawa T, Nishikawa T*: Association study of H2AFZ with schizophrenia in a Japanese case-control sample, J Neural Transm (Vienna), 122:915-923, 2015.
  • Wakuda T, Iwata K, Iwata Y, Anitha A, Takahashi T, Yamada K, Vasu MM, Matsuzaki H, Suzuki K, Mori N: Perinatal asphyxia alters neuregulin-1 and COMT gene expression in the medial prefrontal cortex in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2;56:149-154, 2015.
  • Wakusawa K, Sugiura M, Sassa Y, Jeong H, Yomogida Y, Horie K, Sato S, Yokoyama H, Kure S, Takei N, Mori N, Kawashima R: Adaptive ability to cope with atypical or novel situations involving tool use: An fMRI approach. Neurosci Res. 90:72-82 2015.

2014

  • Balan S, Iwayama Y, Maekawa M, Toyota T, Ohnishi T, Toyoshima M, Shimamoto C, Esaki K, Yamada K, Iwata Y, Suzuki K, Ide M, Ota M, Fukuchi S, Tsujii M, Mori N, Shinkai Y, Yoshikawa T: Exon resequencing of H3K9 methyltransferase complex genes, EHMT1, EHTM2 and WIZ, in Japanese autism subjects. Mol Autism. 5:49,2014.
  • Mundalil Vasu M, Anitha A, Thanseem I, Suzuki K, Yamada K, Takahashi T, Wakuda T, Iwata K, Tsujii M, Sugiyama T, Mori N: Serum microRNA profiles in children with autism. Mol Autism. 5:40, 2014.
  • Shimamoto C, Ohnishi T, Maekawa M, Watanabe A, Ohba H, Arai R, Iwayama Y, Hisano Y, Toyota T, Toyoshima M, Suzuki K, Shirayama Y, Nakamura K, Mori N, Owada Y, Kobayashi T, Yoshikawa T: Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies. Hum Mol Genet. 23:6495-6511, 2014.
  • Miyaoka T, Furuya M, Horiguchi J, Wake R, Hashioka S, Tohyama M, Mori N, Minabe Y, Iyo M, Ueno S, Ezoe S, Murotani K, Hoshino S, Seno H: Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, double-blind, placebo-controlled trial (a Positive and Negative Syndrome Scale, five-factor analysis). Psychopharmacology. 2014 Jun 13. [Epub ahead of print]
  • Anitha A, Thanseem I, Nakamura K, Vasu MM, Yamada K, Ueki T, Iwayama Y, Toyota T, Tsuchiya KJ, Iwata Y, Suzuki K, Sugiyama T, Tsujii M, Yoshikawa T, Mori N: Zinc finger protein 804A (ZNF804A) and verbal deficits in individuals with autism. J Psychiatry Neurosci. 39:294-303, 2014.
  • Iwata K, Matsuzaki H, Tachibana T, Ohno K, Yoshimura S, Takamura H, Yamada K, Matsuzaki S, Nakamura K, Tsuchiya KJ, Matsumoto K, Tsujii M, Sugiyama T, Katayama T, Mori N: N-ethylmaleimide-sensitive factor interacts with the serotonin transporter and modulates its trafficking: implications for pathophysiology in autism. Mol Autism. 5:33, 2014.
  • Muramatsu-Kato K, Itoh H, Kobayashi-Kohmura Y, Murakami H, Uchida T, Suzuki K, Sugihara K, Kanayama N, Tsuchiya KJ, Takei N.: Hamamatsu Birth Cohort (HBC) Study Team. Comparison between placental gene expression of 11β-hydroxysteroid dehydrogenases and infantile growth at 10 months of age. Journal of Obstetric and Gynaecology Research 40:465-72, 2014.

2013

  • Kameno Y, Iwata K, Matsuzaki H, Miyachi T, Tsuchiya KJ, Matsumoto K, Iwata Y, Suzuki K, Nakamura K, Maekawa M, Tsujii M, Sugiyama T, Mori N: Serum levels of soluble platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 are decreased in subjects with autism spectrum disorder. Mol Autism. 4(1):19, 2013.
  • Balan S, Yamada K, Hattori E, Iwayama Y, Toyota T, Ohnishi T, Maekawa M, Toyoshima M, Iwata Y, Suzuki K, Kikuchi M, Yoshikawa T*: Population-specific haplotype association of the postsynaptic density gene DLG4 with schizophrenia, in family-based association studies. PLoS One. 8:e70302, 2013.
  • Balan S, Yamada K, Iwayama Y, Toyota T, Ohnishi T, Maekawa M, Toyoshima M, Iwata Y, Suzuki K, Kikuchi M, Ujike H, Inada T, Kunugi H, Ozaki N, Iwata N, Nanko S, Kato T, Yoshikawa T*: Lack of association of EGR2 variants with bipolar disorder in Japanese population. Gene. 526:246-250, 2013.
  • Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Futatsubashi M, Takebayashi K, Yoshihara Y, Omata K, Matsumoto K, Tsuchiya KJ, Iwata Y, Tsujii M, Sugiyama T, Mori N. Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry. 70(1):49-58, 2013.
  • Tsuchiya KJ, Matsumoto K, Yagi A, Inada N, Kuroda M, Inokuchi E, Koyama T, Kamio Y, Tsujii M, Sakai S, Mohri I, Taniike M, Iwanaga R, Ogasahara K, Miyachi T, Nakajima S, Tani I, Ohnishi M, Inoue M, Nomura K, Hagiwara T, Uchiyama T, Ichikawa H, Kobayashi S, Miyamoto K, Nakamura K, Suzuki K, Mori N, Takei N. Reliability and validity of autism diagnostic interview-revised, Japanese version. J Autism Dev Disord. 43(3):643-62, 2013.
  • Anitha A, Nakamura K, Thanseem I, Matsuzaki H, Miyachi T, Tsujii M, Iwata Y, Suzuki K, Sugiyama T, Mori N. Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol. ;23(3):294-302, 2013.
  • Shimmura C, Suzuki K, Iwata Y, Tsuchiya KJ, Ohno K, Matsuzaki H, Iwata K, Kameno Y, Takahashi T, Wakuda T, Nakamura K, Hashimoto K, Mori N. Enzymes in the glutamate-glutamine cycle in the anterior cingulate cortex in postmortem brain of subjects with autism. Mol Autism. 4(1):6, 2013.
  • Takata A, Iwayama Y, Fukuo Y, Ikeda M, Okochi T, Maekawa M, Toyota T, Yamada K, Hattori E, Ohnishi T, Toyoshima M, Ujike H, Inada T, Kunugi H, Ozaki N, Nanko S, Nakamura K, Mori N, Kanba S, Iwata N, Kato T, Yoshikawa T. A population-specific uncommon variant in GRIN3A associated with schizophrenia. Biol Psychiatry. 73(6):532-9, 2013.

2012

  • Thanseem I, Anitha A, Nakamura K, Suda S, Iwata K, Matsuzaki H, Ohtsubo M, Ueki T, Katayama T, Iwata Y, Suzuki K, Minoshima S, Mori N. Elevated transcription factor Sp1 in autism brains alters the expression of autism candidate genes. Biol Psychiat 71:410-418; 2012.
  • Tsuchiya KJ, Tsutsumi H, Matsumoto K, Takei N, Narumiya M, Honda M, Thanseem I, Anitha A, Suzuki K, Matsuzaki H, Iwata Y, Nakamura K, Mori N; H. B. C. Study Team. Seasonal variations of neuromotor development by 14 months of age: Hamamatsu Birth Cohort for mothers and children (HBC Study). PLoS One. 7(12):e52057, 2012.
  • Anitha A, Nakamura K, Thanseem I, Yamada K, Iwayama Y, Toyota T, Matsuzaki H, Miyachi T, Yamada S, Tsujii M, Tsuchiya KJ, Matsumoto K, Iwata Y, Suzuki K, Ichikawa H, Sugiyama T, Yoshikawa T, Mori N. Brain region-specific altered expression and association of mitochondria-related genes in autism. Mol Autism. 3(1):12, 2012.
  • Iwata K, Izumo N, Matsuzaki H, Manabe T, Ishibashi Y, Ichitani Y, Yamada K, Thanseem I, Anitha A, Vasu MM, Shimmura C, Wakuda T, Kameno Y, Takahashi T, Iwata Y, Suzuki K, Nakamura K, Mori N. Vldlr overexpression causes hyperactivity in rats. Mol Autism. 3(1):11, 2012.
  • Takahashi S, Tsuchiya KJ, Matsumoto K, Suzuki K, Mori N, Takei N; HBC Study Team. Psychosocial determinants of mistimed and unwanted pregnancy: the Hamamatsu Birth Cohort (HBC) study. Matern Child Health J. 16(5):947-55, 2012.
  • Thanseem I, Anitha A, Nakamura K, Suda S, Iwata K, Matsuzaki H, Ohtsubo M, Ueki T, Katayama T, Iwata Y, Suzuki K, Minoshima S, Mori N. Elevated transcription factor specificity protein 1 in autistic brains alters the expression of autism candidate genes. Biol Psychiatry.71(5):410-8, 2012.

2011

  • Nakamura K, Iwata Y, Anitha A, Miyachi T, Toyota T, Yamada S, Tsujii M, Tsuchiya KJ, Iwayama Y, Yamada K, Hattori E, Matsuzaki H, Matsumoto K, Suzuki K, Suda S, Takebayashi K, Takei N, Ichikawa H, Sugiyama T, Yoshikawa T, Mori N. Replication study of Japanese cohorts supports the role of STX1A in autism susceptibility. Prog Neuropsychopharmacol Biol Psychiatry.32(2):454-458, 2011.
  • Takata A, Kim SH, Ozaki N, Iwata N, Kunugi H, Inada T, Ujike H, Nakamura K, Mori N, Ahn YM, Joo EJ, Song JY, Kanba S, Yoshikawa T, Kim YS, Kato T. Association of ANK3 with bipolar disorder confirmed in East Asia. Am J Med Genet B Neuropsychiatr Genet. 156(3):312-315, 2011.
  • Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Tsujii M, Futatsubashi M, Iwata Y, Tsuchiya KJ, Matsumoto K, Takebayashi K, Wakuda T, Yoshihara Y, Suda S, Kikuchi M, Takei N, Sugiyama T, Irie T, Mori N. Reduced acetylcholinesterase activity in the fusiform gyrus in adults with autism spectrum disorders. Arch Gen Psychiatry. 68(3):306-313, 2011.
  • Iwata Y, Suzuki K, Takei N, Toulopoulou T, Tsuchiya KJ, Matsumoto K, Takagai S, Oshiro M, Nakamura K, Mori N. Jiko-shisen-kyofu (fear of one's own glance), but not taijin-kyofusho (fear of interpersonal relations), is an east Asian culture-related specific syndrome. Aust N Z J Psychiatry. 45(2):148-52, 2011.
  • Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, Wakuda T, Sugihara G, Takebayashi K, Suda S, Iwata Y, Ueki T, Tsuchiya KJ, Suzuki K, Nakamura K, Ouchi Y. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 38(2):343-51, 2011.

2010

  • Thanseem I, Nakamura K, Miyachi T, Toyota T, Yamada S, Tsujii M, Tsuchiya KJ, Anitha A, Iwayama Y, Yamada K, Hattori E, Matsuzaki H, Matsumoto K, Iwata Y, Suzuki K, Suda S, Kawai M, Sugihara G, Takebayashi K, Takei N, Ichikawa H, Sugiyama T, Yoshikawa T, Mori N. Further evidence for the role of MET in autism susceptibility. Neurosci Res. 68(2):137-41, 2010.
  • Katoh Y, Uchida S, Kawai M, Takei N, Mori N, Kawakami J, Kagawa Y, Yamada S, Namiki N, Hashimoto H. Onset of clinical effects and plasma concentration of fluvoxamine in Japanese patients. Biol Pharm Bull. 33(12):1999-2002, 2010.
  • Arai M, Yuzawa H, Nohara I, Ohnishi T, Obata N, Iwayama Y, Haga S, Toyota T, Ujike H, Arai M, Ichikawa T, Nishida A, Tanaka Y, Furukawa A, Aikawa Y, Kuroda O, Niizato K, Izawa R, Nakamura K, Mori N, Matsuzawa D, Hashimoto K, Iyo M, Sora I, Matsushita M, Okazaki Y, Yoshikawa T, Miyata T, Itokawa M. Enhanced carbonyl stress in a subpopulation of schizophrenia. Arch Gen Psychiatry. 67(6):589-97, 2010.
  • Suzuki K, Iwata Y, Matsuzaki H, Anitha A, Suda S, Iwata K, Shinmura C, Kameno Y, Tsuchiya KJ, Nakamura K, Takei N, Mori N. Reduced expression of apolipoprotein E receptor type 2 in peripheral blood lymphocytes from patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 34(6):1007-10, 2010.
  • Iwata Y, Yamada K, Iwayama Y, Anitha A, Thanseem I, Toyota T, Hattori E, Ohnishi T, Maekawa M, Nakamura K, Suzuki K, Matsuzaki H, Tsuchiya KJ, Suda S, Sugihara G, Takebayashi K, Yamamoto S, Iwata K, Mori N, Yoshikawa T. Failure to confirm genetic association of the FXYD6 gene with schizophrenia: the Japanese population and meta-analysis. Am J Med Genet B Neuropsychiatr Genet. 153B(6):1221-7, 2010.
  • Munesue T, Yokoyama S, Nakamura K, Anitha A, Yamada K, Hayashi K, Asaka T, Liu HX, Jin D, Koizumi K, Islam MS, Huang JJ, Ma WJ, Kim UH, Kim SJ, Park K, Kim D, Kikuchi M, Ono Y, Nakatani H, Suda S, Miyachi T, Hirai H, Salmina A, Pichugina YA, Soumarokov AA, Takei N, Mori N, Tsujii M, Sugiyama T, Yagi K, Yamagishi M, Sasaki T, Yamasue H, Kato N, Hashimoto R, Taniike M, Hayashi Y, Hamada J, Suzuki S, Ooi A, Noda M, Kamiyama Y, Kido MA, Lopatina O, Hashii M, Amina S, Malavasi F, Huang EJ, Zhang J, Shimizu N, Yoshikawa T, Matsushima A, Minabe Y, Higashida H. Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neurosci Res. 67(2):181-91, 2010.
  • Kushima I, Aleksic B, Ito Y, Nakamura Y, Nakamura K, Mori N, Kikuchi M, Inada T, Kunugi H, Nanko S, Kato T, Yoshikawa T, Ujike H, Suzuki M, Iwata N, Ozaki N. Association study of ubiquitin-specific peptidase 46 (USP46) with bipolar disorder and schizophrenia in a Japanese population. J Hum Genet. 55(3):133-6, 2010.
  • Fujita-Shimizu A, Suzuki K, Nakamura K, Miyachi T, Matsuzaki H, Kajizuka M, Shinmura C, Iwata Y, Suda S, Tsuchiya KJ, Matsumoto K, Sugihara G, Iwata K, Yamamoto S, Tsujii M, Sugiyama T, Takei N, Mori N. Decreased serum levels of adiponectin in subjects with autism. Prog Neuropsychopharmacol Biol Psychiatry. 34(3):455-8, 2010.
  • Maekawa M, Iwayama Y, Arai R, Nakamura K, Ohnishi T, Toyota T, Tsujii M, Okazaki Y, Osumi N, Owada Y, Mori N, Yoshikawa T. Polymorphism screening of brain-expressed FABP7, 5 and 3 genes and association studies in autism and schizophrenia in Japanese subjects. J Hum Genet. 55(2):127-30, 2010.
  • Suzuki K, Nishimura K, Sugihara G, Nakamura K, Tsuchiya KJ, Matsumoto K, Takebayashi K, Isoda H, Sakahara H, Sugiyama T, Tsujii M, Takei N, Mori N. Metabolite alterations in the hippocampus of high-functioning adult subjects with autism. Int J Neuropsychopharmacol. 13(4):529-34, 2010.
  • Katoh Y, Uchida S, Kawai M, Takei N, Mori N, Kawakami J, Kagawa Y, Yamada S, Namiki N, Hashimoto H. Effects of cigarette smoking and cytochrome P450 2D6 genotype on fluvoxamine concentration in plasma of Japanese patients. Biol Pharm Bull. 33(2):285-8, 2010.
  • Kajizuka M, Miyachi T, Matsuzaki H, Iwata K, Shinmura C, Suzuki K, Suda S, Tsuchiya KJ, Matsumoto K, Iwata Y, Nakamura K, Tsujii M, Sugiyama T, Takei N, Mori N. Serum levels of platelet-derived growth factor BB homodimers are increased in male children with autism. Prog Neuropsychopharmacol Biol Psychiatry. 34(1):154-8, 2010.
  • Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K, Matsuzaki H, Suda S, Sugiyama T, Takei N, Mori N. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry. 67(1):59-68, 2010.

2009

  • Watanabe T, Ogai Y, Koga T, Senoo E, Nakamura K, Mori N, Ikeda K. Assessment of Japanese stimulant control law offenders using the Addiction Severity Index--Japanese version: comparison with patients in treatment settings. Int J Environ Res Public Health. 6(12):3056-69, 2009.
  • Takahashi T, Zhu Y, Hata T, Shimizu-Okabe C, Suzuki K, Nakahara D. Intracranial self-stimulation enhances neurogenesis in hippocampus of adult mice and rats. Neuroscience. 158(2):402-411, 2009.
  • Maekawa M, Iwayama Y, Nakamura K, Sato M, Toyota T, Ohnishi T, Yamada K, Miyachi T, Tsujii M, Hattori E, Maekawa N, Osumi N, Mori N, Yoshikawa T. A novel missense mutation (Leu46Val) of PAX6 found in an autistic patient. Neurosci Lett. 462(3):267-71, 2009.
  • Nakamura K, Sekine Y, Takei N, Iwata Y, Suzuki K, Anitha A, Inada T, Harano M, Komiyama T, Yamada M, Iwata N, Iyo M, Sora I, Ozaki N, Ujike H, Mori N. An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis. Neurosci Lett. 455(2):120-3, 2009.
  • Hattori E, Toyota T, Ishitsuka Y, Iwayama Y, Yamada K, Ujike H, Morita Y, Kodama M, Nakata K, Minabe Y, Nakamura K, Iwata Y, Takei N, Mori N, Naitoh H, Yamanouchi Y, Iwata N, Ozaki N, Kato T, Nishikawa T, Kashiwa A, Suzuki M, Shioe K, Shinohara M, Hirano M, Nanko S, Akahane A, Ueno M, Kaneko N, Watanabe Y, Someya T, Hashimoto K, Iyo M, Itokawa M, Arai M, Nankai M, Inada T, Yoshida S, Kunugi H, Nakamura M, Iijima Y, Okazaki Y, Higuchi T, Yoshikawa T. Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet. 150B(8):1110-7, 2009.
  • Anitha A, Nakamura K, Yamada K, Iwayama Y, Toyota T, Takei N, Iwata Y, Suzuki K, Sekine Y, Matsuzaki H, Kawai M, Thanseem I, Miyoshi K, Katayama T, Matsuzaki S, Baba K, Honda A, Hattori T, Shimizu S, Kumamoto N, Kikuchi M, Tohyama M, Yoshikawa T, Mori N. Association studies and gene expression analyses of the DISC1-interacting molecules, pericentrin 2 (PCNT2) and DISC1-binding zinc finger protein (DBZ), with schizophrenia and with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet. 150B(7):967-76, 2009.

総説

2019

  • 山末英典: 社会的コミュニケーションの障害の客観定量化, 分子精神医学19 (2): 2-6, 2019.
  • 山末英典: 新規な自閉スペクトラム症中核症状治療薬の開発〜オキシトシンを軸とした基礎と臨床の融合〜, 神経内科90 (3): 263-260, 2019.
  • 山末英典: 自閉スペクトラム症に対するオキシトシン投与効果の検討における進展, 医学のあゆみ268 (3): 204-207, 2019.
  • 桑原斉、池谷和: 発達障害と合理的配慮、育ちの科学、32、66-71、2019.

2018

  • 山末英典「自閉スペクトラム症に対するオキシトシン治療効果の医師主導 Randomized Controlled Trial -マルチモダリティ脳画像解析の応用-」生物学的精神医学会誌29: 109-113, 2018
  • 桑原斉、池谷和:犯罪・触法行為と自閉スペクトラム症、児童青年精神医学とその近接領域、59、148-158、2018
  • 池谷和、桑原斉、高貝就:ASDの過剰診断を防ぐために、精神科、33、257-261、2018
  • 山末英典: オキシトシン受容体遺伝子, 分子精神医学18: 47-49, 2018
  • 山末英典: オキシトシンと社会脳、自閉症, 生体の科学69: 73-76, 2018
  • 山末英典: 自閉スペクトラム症中核症状に対するオキシトシン治療〜マルチモダリティ脳画像解析とゲノム薬理学の応用〜, 臨床精神医学47: 275-281, 2018
  • 栗田大輔, 竹林淳和: 神経性やせ症に対する包括的入院治療プログラム―静岡県摂食障害診療ネットワークの構築―, 日本精神神経学会誌, 120, 85-92, 2018
  • Seico Benner, Yamasue H*. Clinical Potential of Oxytocin in Autism Spectrum Disorder: Current Issues and Future Perspectives. Behavioral Pharmacology, Behav Pharmacol. 2018 Feb;29(1):1-12.


2017

  • Yamasue H*, Domes G*. Oxytocin and Autism Spectrum Disorders. Curr Top Behav Neurosci. 2017 Aug 2.
  • 山末英典: マルチモダリティ脳画像解析による自閉スペクトラム症中核症状に対するオキシトシン経鼻剤の効果判定, 教育と医学 772: 67-73, 2017年10月号
  • 山末英典: オキシトシンとマルチモダリティ脳画像解析を応用した自閉スペクトラム症中核症状に対する治療薬開発, 分子精神医学17(4): 15-21, 2017.
  • 山末英典: 自閉スペクトラム症中核症状に対する治療薬開発〜オキシトシン経鼻剤とマルチモダリティ脳画像解析の応用〜, 臨床精神薬理20巻6号:621-628, 2017.
  • 山末英典: 自閉スペクトラム症におけるオキシトシンの効果, 日本医師会雑誌 145(11):2372, 2017.
  • 山末英典: 自閉スペクトラム症のVoxel Based Morphometry, BRAIN and NERVE 69(5): 529-538, 2017.
  • 山末英典: 自閉スペクトラム症へのオキシトシン治療の可能性〜自主臨床試験へのマルチモダリティ脳画像解析の応用〜, 発達障害医学の進歩29集;55-62, 2017.
  • 山末英典: 自閉スペクトラム症へのオキシトシン治療の可能性, JLNEWS(日本発達障害連盟ニュース)113: 7, 2017.
  • 山末英典: 精神症状の客観定量化-表出と内的処理過程の乖離-, 最新精神医学 22(2): 79「巻頭言」, 2017.
  • 山末英典: 巻頭言-精神疾患研究における「必要性」について-精神医学 59(2):104-105, 2017.
  • 和久田智靖: 抗NMDA受容体脳炎に見られる精神症状と不随意運動の治療アプローチ, 臨床精神薬理, 20巻4号, 399-406, 2017.
  • 栗田大輔: 女性の摂食障害のケア, 産婦人科の実際, 66巻,293-298,2017
  • 望月洋介: 臥褥再考 その意義と補完 浜松医科大学における臥褥の意義と補完,日本森田療法学会雑誌28(1),45-49,2017.

2016

  • 山末英典: オキシトシン点鼻薬の自閉スペクトラム症に対する臨床応用 内分泌 糖尿病 代謝内科 43(1):73-78, 2016.
  • 山末英典: 脳画像で精神疾患の何が分かるのか, 精神科臨床Legato 2(4):20-25, 2016.
  • Asakawa T, Fang H, Sugiyama K, Nozaki T, Hong Z, Yang Y, Hua F, Ding G, Chao D, Fenoy AJ, Villarreal SJ, Onoe H, Suzuki K, Mori N, Namba H, Xia Y: Animal behavioral assessments in current research of Parkinson's disease, Neurosci Biobehav Rev, 65:63-94, 2016.
  • 竹林淳和: 【摂食障害の治療update】摂食障害治療支援センター, 精神科, 28:40-45, 2016.

2015

  • 鈴木勝昭: 脳の科学Up Date 精神疾患と脳画像, 脳21, 18:211-214, 2015.
  • 竹林淳和: 摂食障害 拒食症の入院治療プログラムについて 摂食障害の包括的治療と施設間連携, 児童青年精神医学とその近接領域, 56:562-565, 2015.
  • 望月洋介: 【明日からできる摂食障害の診療II】摂食障害の家族心理教育グループ(家族教室), 精神科臨床サービス, 15:471-476, 2015.
  • 大隅香苗, 高貝就, 辻井正次: 自閉症スペクトラム障害研究におけるVineland適応行動尺度の有用性について, 子どものこころと脳の発達, 6:5-15, 2015.
  • 土屋賢治, 服巻智子, 和久田学, 新村千江, 首藤勝行, 大須賀優子, 村田絵美, 坂鏡子, 中原竜治, 浅野良輔, 高貝就, 鈴木勝昭, 森則夫, 黒木俊秀, 片山泰一: GazeFinder (Ka-o-TV) を用いた自閉スペクトラム症の早期診断指標の開発 1歳6ヵ月乳幼児健診における活用に向けて, 脳21, 18:203-213, 2015.
  • 松崎秀夫, 東田陽博, 森則夫: 予防精神医学の可能性を探る 脂質代謝特性に基づく自閉症予防法開発の試み, 児童青年精神医学とその近接領域, 56:616-620, 2015.

2013

  • 森則夫: 精神疾患とマイクログリア, 脳21, 16:15-22, 2013.
  • 鈴木勝昭: 自閉症スペクトラム障害の脳病態の分子イメージング PET研究. 脳21. 16:186-192, 2013.
  • 梅田亜沙子, 惠藤絢香, 岩永竜一郎, 鈴木勝昭, 辻井正次: 発達障害児・者の感覚刺激への反応異常の評定 Sensory Profileについて. 子どものこころと脳の発達. 4:53-61, 2013.

2012

  • 伊熊正光, 鈴木勝昭, 土屋賢治, 中村和彦, 辻井正次, 森則夫. 高機能自閉症スペクトラム障害者における脳内コリン系の異常. 子どものこころと脳の発達 3:17-22, 2012.
  • Matsuzaki H, Iwata K, Manabe T, Mori N:Triggers for autism: genetic and environmental factors. Journal of Central Nervous System Disease.4:1-10. 2012.
  • 鈴木勝昭、杉山登志郎:自閉症スペクトラムと脳. Brain Medical 24: 309-316, 2012.

2011

  • 鈴木勝昭:アスペルガー症候群の生物学的知見. そだちの科学 17: 12-20, 2011.
  • 鈴木勝昭:脳の基盤の問題(Abnormal Brain Condition)として明らかになったこと-PET研究が明らかにしたこと. アスペハート 28: 36-39, 2011.
  • 鈴木勝昭, 中村和彦, 森則夫:【注目の遺伝子】自閉症における脳内アセチルコリンエステラーゼ活性の低下. 分子精神医学 11: 211-213, 2011.
  • 鈴木勝昭:バイオマーカーからみた自閉症スペクトラム障害. 小児の精神と神経 51: 133-142, 2011.
  • 井上淳, 望月洋介, 大隅香苗, 岩田泰秀, 鈴木勝昭, 森則夫:【強迫性障害の診断, 症状, 治療について】 強迫性障害の森田療法による治療について. 脳21 14: 262-266, 2011.
  • 和久田学, 櫻井典啓, 鈴木勝昭:我が国の特別支援教育の現状と課題-米国との比較から,これから何をすべきか考える-. 子どものこころと脳の発達 2: 46-53, 2011.

2010

  • 中村和彦:精神疾患の遺伝子は、本当に見つかったのか?自閉症障害 分子遺伝子学研究の現状とセロトニン系に関連して, 分子精神医学, 2010 ; 20: 281-286.
  • Iwata K, Matsuzaki H, Takei N, Manabe T,Mori N. :Animal models of autism: an epigenetic and environmental viewpoint.Journal of Central Nervous System Disease,2, 37-44.2010(*Correspondence author)
  • 鈴木勝昭,中村和彦,尾内康臣,辻井正次,森則夫.【多分野連携と子どものこころの解明への試み】自閉症の脳画像研究について.脳21. 13: 25-28, 2010.

2009

  • 鈴木勝昭,尾内康臣,中村和彦,杉原玄一,竹林淳和,武井教使,森 則夫:【自閉症研究の最近の話題】自閉症脳における神経生化学的所見-proton MRS, SPECT, PET.脳と精神の医学20:281-6, 2009.

2008

  • 中村和彦,土屋賢治,八木敦子,松本かおり,宮地泰士,辻井正次,森則夫. :成人期アスペルガー症候群のADI-R(自閉症診断面接改訂版)による診断―生物学的研究との関連でー.精神医学50(8): 787-799. 2008.

著書

2019

  • 井上猛、桑原斉、酒井隆、鈴木映二、水上勝義、宮田久嗣、諸川由美代、吉尾隆、渡邉博幸(編): こころの治療薬ハンドブック(第12版)、星和書店、2019.

2018

  • 下山晴彦(監修)、桑原斉、田中康雄、稲田尚子、黒田美保(編著):公認心理師のための「発達障害」講義、北大路書房、2018.

2015

  • 森則夫、杉山登志郎、和久田智靖(編著):『浜松医大流 エビデンスに基づく精神療法実践集』、金芳堂、 2015.

2014

  • 森則夫、杉山登志郎、岩田泰秀(編著):臨床家のためのDSM-5虎の巻、日本評論社、2014.
  • 栗田大輔 (著)、 森則夫 (監修):精神科医もできる!拒食症身体治療マニュアル、金芳堂、2014.

症例報告

2019

  • Wakuda T, Suzuki A, Hasegawa M, Ichikawa D, Yamasue H. Acute agranulocytosis when switching from risperidone to paliperidone. Aust N Z J Psychiatry. 2019 Jan 14:4867418821441. doi: 10.1177/0004867418821441.

講演・学会発表等

2018

  • Hidenori Yamasue "Development of oxytocin as a novel therapeutic for autism spectrum core symptoms" Cold Spring Harbor Asia. Sozhou, China, Sep 17-21, 2018.
  • Hidenori Yamasue "Genes and effects of oxytocin on autistic social behaviors and their neural underpinings" Understanding the Neuroregulatory Actions of Oxytocin and its Potential Clinical Applications. Sicily, Italy, MAY 22-27, 2018.
  • Hidenori Yamasue "Applications of multimodal neuroimaging and pharmacogenetics to develop oxytocin as a novel therapeutic for autism spectrum core symptoms" in a symposia: "Emerging therapeutic targets against autism spectrum disorder." 18th World Congress of Basic and Clinical Pharmacology, 4th July, 2018, Kyoto, Japan.
  • Wakuda T, Yokokura M, Nakaizumi K, Kato Y, Kameno Y, Futatsubashi M, Yoshikawa E, Magata Y, Ouchi Y, Yamasue H, Takei N: A pilot study of [11C] (R)-MeQAA PET brain imaging analysis of alpha 7 nicotinic acetylcholine receptors availability in schizophrenia. Schizophrenia International Research Congress. 2018.4. Florence, Italy
  • Yokokura M, Yamasue H, Ouchi H. "Activated microglia in attention-deficit/hyperactivity disorder: a positron emission tomography study." The world federation of society of biological psychiatry (WFSBP) 2018, JAPAN, 2018/9/7-9.
  • Yasuhiko Kato, Hitoshi Kuwabara, Takashi Okada, Toshio Munesue, Miho Kuroda, Masaki Kojima, Walid Yassin, Seico Benner, Yosuke Eriguchi, Yosuke Kameno, Chihiro Murayama, Teruko Yuhi, Norio Ozaki, Hirotaka Kosaka, Hidenori Yamasue "Metabolomic characteristics and oxytocin's efficacy on them in autism spectrum disorder" Cold Spring Harbor Asia. Sozhou, China, Sep 17-21, 2018.
  • Chihiro Murayama, Hitoshi Kuwabara, Takashi Okada, Toshio Munesue, Miho Kuroda, Masaki Kojima, Walid Yassin, Seico Benner, Yosuke Eriguchi, Yosuke Kameno, Yasuhiko Kato, Teruko Yuhi, Junichi Masuda, Norio Ozaki, Hirotaka Kosaka, Hidenori Yamasue "Involvement of the kynurenine pathway in the effect of oxytocin on adult males with ASD: an exploratory study" Cold Spring Harbor Asia. Sozhou, China, Sep 17-21, 2018.
  • Hidenori Yamasue "Development of novel therapeutics for autism spectrum core symptoms utilizing oxytocin, neuroimaging, and genetic analyses." 28th JSBN, Social Neural Networks Research Unit Kickoff Symposium. Tsukuba, Japan, 3rd Mar, 2018.
  • Hidenori Yamasue "Applications of multimodal neuroimaging indices and genetics to develop oxytocin as a novel therapeutic for autism spectrum disorder" The 4th Symposium of Neuroscience Network in Kobe 16th Feb, 2018, Kobe, Japan.
  • Yokokura M, Terada T, Bunai T, Nakaizumi K, Yasuhiko Kato, Futatsubashi M, Yoshikawa E, Yamasue H, Ouchi Y: "Activated microglia increased in anorexia nervosa: a [11C]DPA713 PET study" The 17th conference of peace through mind/brain science, 2018.

2017

  • 山末英典 "Oxytocin-related genotypes and effects of oxytocin on autistic social behaviors and their neural underpinings" Plenary lecture in International Autism Conference Tokyo 2017、2017年10月15日、一ツ橋.
  • Hidenori Yamasue. "Development of intranasal oxytocin as treatment of autism spectrum disorder utilizing brain functional imaging." Symposium on Oxytocin and Social Behavior, 4th July, 2017, Hamamatsu, Japan.
  • 山末英典「Human Brain Structural Change Related to Acute Single Exposure to Sarin」GHSAG Chemical Event Symposium、2017年11月20日、大阪
  • Yokokura M, Terada T, Bunai T, Nakaizumi K, Yasuhiko Kato, Futatsubashi M, Yoshikawa E, Ouchi Y: "Increased microglial activation in anorexia nervosa: a [11C]DPA713 PET study" Neuroscience 2017, Nov.11-15,2017.

2016

  • Hidenori Yamasue "An application of neuroimaging to satisfy unmet medical needs associated with autism spectrum disorders" JSBN-RIEMS joint Symposium "International educational symposium of prosocial behavior", 25th JSBN, Sep 14, 2016, Atami, Shizuoka
  • 山末英典「遺伝子情報による自閉スペクトラム症に対するオキシトシン投与効果の予測」神経科学学会との合同シンポジウム:脳科学から見た自閉スペクトラム症 第46回日本神経精神薬理学会年会、2016年7月2日、ソウル、韓国
  • Yokokura M, Terada T, Bunai T, Nakaizumi K, Takebayashi K, Futatsubashi M, Yoshikawa E, Ouchi Y: "Reduced serotonin transporter availability in anorexia nervosa: a [11C]DASB PET study" Neuroscience 2016, Nov.12-16,2016. USA.


2015

  • Yokokura M:"A comparison study of microglial activation in aging and dementia between first- and second-generation TSPO PET tracers: [11C]PK11195 and [11C]DPA713.", Neuroscience2015, 平成27年10月17~23日、Chikago, USA.

2013

  • Yokokura M:Depiction of microglial activation in the living human brain by different TSPO tracers, Neuroscience2013, November 2013, San Diego, USA.

2012

  • Iwata K, Matsuzaki H, Wakuda T, Takei N., Mori N.: Alteration of the expression balance of hnRNP C1 and C2 changes the expression of myelination- and schizophrenia-related genes in the human neuroblastima cell line. 3rd Schizophrenia International Research Society Conference. April 14-18, 2012, Florence, Italy.
  • Wakuda T., Iwata K., Suzuki K., Takei N., Mori N.: Alteration of several schizophrenia candidate genes expression in medial prefrontal cortex in perinatal apsyxia rodent model. 3rd Schizophrenia International Research Society Conference. April 14-18, 2012, Florence, Italy.
  • Yoshihara Y, Sugihara G, Ishizuka A, Yogo H, Nakamura K, Sugiyama T, Matsumoto K, Tsuchiya KJ, Suzuki K, Takei N, Tsujii M, Mori M.:Glutamate dysfunction in the basal ganglia of autism spectrum disorders: an MRS study. The 11th International Meeting for Autism Research, May 17-19, 2012. Toronto,Canada.

2011

  • Suzuki K:Molecular Imaging in Methamphetamine Abuse. Society of Biological Psychiatry 66th Annual meeting 2011 San Francisco, USA
  • Matsuzaki H, Iwata K, Tsuchiya KJ, Itoh H, Mori N:VLDL-specific hypolipidemia pattern in human subjects with autism and autistic rodent models. The 7th World Congress on Developmental Origins of Health and Disease, September 18-21 2011. Portland, USA

2010

  • Nakamura K, Ouchi Y, Tsujii M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K, Matsuzaki H, Suda S, Sugoyama T, Takei N, Mori N. : Brain serotonin and dopamine transporter bindings in adults with autism. 9thAnnual International Meeting For Autism Reserch,May 20, 2010. Philadelphia, USA
  • Nakamura K,Ouchi Y, Tsujii M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K, Matsuzaki H, Suda S, Sugoyama T, Takei N, Mori N. : Brain serotonin and dopamine transporter bindings in adults with autism. 40thAnnual Meeting of The Society for Neuroscience, November, 2010, San Diego, USA.
  • Wakuda T, Suda S, Iwata K, Suzuki K, Mori N, Takei N. : Alteration of AKT1 and Neuregulin-1 gene expression in frontal cortex and dentate gyrus may be associated with schizophrenia: perinatal asphyxia model in rat.Schizophrenia International Research Congress. 2010Apr.Florence, Italy.
  • Tsuchiya KJ, Matsumoto K, Takahashi S, Mori T, Takabayashi R, Suzuki Y, Sato R, Narumiya M, Seno Y, Suda S, Matsuzaki H, Suzuki K, Mori N, Takei N. : the HBC Study Team. Early- and late-onset postpartum depression and the associated risk factors: the HBC Study. Longitudinal and Life Course Studies 1 (suppl 3): 374, October13-15, 2010, Paphos, Cyprus.
  • Matsuzaki H, Iwata K, Suda S, Tsuchiya KJ, Suzuki K, NakamuraK, Tsujii M, Takei N, Mori N. Dyslipidemia in male patients with high-functioning autism. The 9thannual International Meeting for Autism Research, May 20, 2010, Philadelphia, USA
  • Matsuzaki H, Fujita-Shimizu A, Iwata K, Suda S, Shimmura C, Kameno Y, Mori N. :Serum adipokine levels in children with autism. The Society for Neuroscience 40th annual meeting, November 16, 2010, San Diego, USA.
  • Iwata K, Matsuzaki H, Izumo N, Ichitani, Y, Mori N. : VLDLR overexpression rat:evaluationas an animal model of autism.Society for neuroscience ,November13-16,2010,San Diego ,USA.
  • Shimmura C, Suda S, Tsuchiya K.J, Hashimoto K, Ohno K, Matsuzaki M, Iwata K, Kameno Y, Nakamura K, Takei N, Mori N.:Dysregulation of glutamatergic biosynthetic pathway in subjects with autism. The Society for Neuroscience 40th annual meeting, November 16,2010, San Diego, USA.

2009

  • Nakamura K, Miyachi T, Ayyappan A, Tsujii M, Suda S, Thanseem I, Tsuchiya K, Matsuzaki H,Yamada K, Iwayama}; Y, Toyota T, Hattori E, Sugiyama T, Takei N, Yoshikawa T, Mori N. Genetic and Expression Analyses of Serotonergic Factors in Autism. 8thAnnual International Meeting For Autism Research,May, 2009. Chicago, USA

2008

  • Yoshihara Y, Sugihara G, Suckling J, Isoda H, Sakahara H,Mori N, Takei N. : Voxel-based structural MRI study of patients with early-onset schizophrenia. The 1st Schizophrenia International Research Society Conference, Venice, Italy.
  • Nakamura K, Matsuzaki H, Tsujii M, Ayyappan A, Yamada K, Suda S, Iwayama Y, Miyachi T, Tsuchiya K, Sugiyama T, Takei N, Yoshikawa T, Mori N. : Genetic analyses of serotonergic factors in autism. 7thAnnual International Meeting For Autism Research, London.